Whole-genome sequencing maps genetic roots of albinism

A single eye movement, recorded in an infant, can carry a genetic story that previously took years to read. Researchers publishing in npj Genomic Medicine have used whole-genome sequencing to trace that story more precisely than before.

The study examined people with albinism and infantile nystagmus — an involuntary, rhythmic movement of the eyes that commonly accompanies albinism from birth. Using whole-genome sequencing, the researchers identified a wider range of genetic causes behind these conditions than earlier, narrower methods had captured, according to the published findings.

What the sequencing revealed

Whole-genome sequencing reads the full length of a person's DNA, rather than targeting only known regions of interest. The study found that this broader approach uncovered genetic variants that would have been missed by standard diagnostic panels, the researchers reported. Those variants were linked to distinct phenotypic signatures — meaning specific, observable patterns in how albinism and nystagmus appear and behave in different individuals.

The findings suggest that what clinicians currently group together under shared diagnoses may in fact represent several genetically distinct conditions, according to the study. That distinction matters: different genetic causes can influence prognosis, inheritance risk, and, as gene-based therapies develop, eligibility for treatment.

Why this level of detail is new

Previous genetic testing for albinism has typically relied on targeted gene panels — tests designed around a fixed list of genes already known to be involved. Whole-genome sequencing places no such boundary on the search. The npj Genomic Medicine study reported that this unrestricted approach raised the diagnostic yield, meaning more patients received a confirmed genetic explanation for their condition than panel-based testing would have provided.

The researchers also noted associations between specific genetic variants and specific visual or pigmentation presentations. These phenotypic signatures, the study found, could in time help clinicians anticipate how a condition is likely to progress based on its genetic origin alone.

For families navigating a diagnosis, that kind of precision carries weight. Knowing the exact genetic pathway involved changes the questions a specialist can answer — and the certainty with which they can answer them.

The study was published in npj Genomic Medicine, a Nature Portfolio journal focused on the clinical application of genomic research. As whole-genome sequencing becomes more accessible in healthcare settings, findings like these point toward a more individualised understanding of albinism — one gene, one variant, one person at a time.